Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Frontiers in Pharmacology
|
July 1, 2021
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
Cell Reports
|
December 1, 2021
Synaptic protein interaction networks encode experience by assuming stimulus-specific and brain-region-specific states
Jonathan D Lautz, Kaleb B Tsegay, Zhiyi Zhu, et al.
Scientific Reports
|
July 28, 2019
Activity-dependent changes in synaptic protein complex composition are consistent in different detergents despite differential solubility
Jonathan D Lautz, Edward P Gniffke, Emily A Brown, et al.
Biorxiv : the Preprint Server for Biology
|
April 14, 2021
A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
The Journal of Infectious Diseases
|
August 17, 2020
Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay
Edward P Gniffke, Whitney E Harrington, Nicholas Dambrauskas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 25, 2020
Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay
Edward P Gniffke, Whitney E Harrington, Nicolas Dambrauskas, et al.
Science Signaling
|
May 5, 2021
Remodeling of the Homer-Shank interactome mediates homeostatic plasticity
Whitney E Heavner, Jonathan D Lautz, Haley E Speed, et al.
Molecular Autism
|
September 22, 2018
Clustering the autisms using glutamate synapse protein interaction networks from cortical and hippocampal tissue of seven mouse models
Emily A Brown, Jonathan D Lautz, Tessa R Davis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Frontiers in Pharmacology
|
July 1, 2021
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
Cell Reports
|
December 1, 2021
Synaptic protein interaction networks encode experience by assuming stimulus-specific and brain-region-specific states
Jonathan D Lautz, Kaleb B Tsegay, Zhiyi Zhu, et al.
Scientific Reports
|
July 28, 2019
Activity-dependent changes in synaptic protein complex composition are consistent in different detergents despite differential solubility
Jonathan D Lautz, Edward P Gniffke, Emily A Brown, et al.
Biorxiv : the Preprint Server for Biology
|
April 14, 2021
A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
The Journal of Infectious Diseases
|
August 17, 2020
Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay
Edward P Gniffke, Whitney E Harrington, Nicholas Dambrauskas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 25, 2020
Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay
Edward P Gniffke, Whitney E Harrington, Nicolas Dambrauskas, et al.
Science Signaling
|
May 5, 2021
Remodeling of the Homer-Shank interactome mediates homeostatic plasticity
Whitney E Heavner, Jonathan D Lautz, Haley E Speed, et al.
Molecular Autism
|
September 22, 2018
Clustering the autisms using glutamate synapse protein interaction networks from cortical and hippocampal tissue of seven mouse models
Emily A Brown, Jonathan D Lautz, Tessa R Davis, et al.
Page
of 1